Breaking News

Sartorius Stedim Biotech Launches Chemistry Testing Services

To be offered by subsidiary BioOutsource

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Biotech (SSB) has launched a full range of chemistry testing services. Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have been developed to ensure rapid sample analysis and reporting for mAbs and biosimilars. This range of chemistry testing services complies with the ICH Q6B scientific guidelines for pharmaceuticals for human use, and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters